Prices plus VAT plus shipping costs
Ready to ship today,
Delivery time appr. 5-8 days
- Order number: 7TM0361N
- Content: 100 µl
- Host: Rabbit
The NK2 antibody is directed against the distal end of the carboxyl-terminal tail of human Tachykinin Receptor 2. It detects selectively the NK2 Tachykinin Receptor. It can be used to detect total NK2 receptors in Western blots independent of phosphorylation. The NK2 antibody can also be used to isolate and enrich NK2 receptors from brain lysates. It also detects NK2 in cultured cells and tissue sections by immunohistochemistry.
| Alternative Names | NK2, SKR, TACR2, Neurokinin B Receptor, Substance K Receptor |
| IUPHAR Target ID | 361 |
| UniProt ID | P21452 |
| Western Blot (WB) | 1:1000 |
| Immunohistochemistry (IHC) | 1:100 |
| Species Reactivity | Human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Immunogen | A synthetic peptide corresponding to distal end of carboxy-terminal tail of human NK2. |
| Form | Liquid |
| Purification | Antigen affinity chromatography |
| Storage buffer | Dulbecco's PBS, pH 7.4, with 150 mM NaCl, 0.02% sodium azide |
| Storage conditions | short-term 4°C, long-term -20°C |
Figure 1. Validation of the Tachykinin Receptor 2 in transfected HEK293 cells. Native HEK293 cells (MOCK) or HEK293 cells stably expressing the Tachykinin Receptor 2 (NK2) were lysed and immunoblotted with the anti-NK2 antibody (7TM0361N) at a dilution of 1:1000.
Figure 2. Immunohistochemical identification of Tachykinin Receptor 2 in renal cell carcinoma. Sections were dewaxed, microwaved in citric acid, and incubated with anti-NK2 (Tachykinin Receptor 2) antibody (7TM0361N) at a dilution of 1:100. Sections were then sequentially treated with biotinylated anti-rabbit IgG and avidin-biotin solution. Sections were then developed in 3,3-diaminobenzidine (DAB)-glucose oxidase and lightly counterstained with hematoxylin.
Figure 3. Immunohistochemical identification of Tachykinin Receptor 2 in duodenum. Sections were dewaxed, microwaved in citric acid, and incubated with anti-NK2 (Tachykinin Receptor 2) antibody (7TM0361N) at a dilution of 1:100. Sections were then sequentially treated with biotinylated anti-rabbit IgG and avidin-biotin solution. Sections were then developed in 3,3-diaminobenzidine (DAB)-glucose oxidase and lightly counterstained with hematoxylin.



